Haem 3 Flashcards
malignant haemopiesis is what
increased number of dysfunctional cells that have lost the normal haemopoiteic reserve
one or more of what is in malignant haemopoiesis
increased proliferation
lack of differentiation
lack of maturation
loss of apoptosis
acute leukaemia
abnormal proliferation and lack of maturation
ix for acute leukaemia
excess of blasts >20% in either peripheral blood or bone marrow
decreased/ loss of normal haemopoietic reserve
ALL is a malig disease of what
most common what
symptoms
malig disease of lymphocytes
most common childhood cancer
very severe bone pain, BM failure : infections, bleeding, anaemia
increased WCC, venous obstruction, CNS involvement
AML in who may be what of two similar to what subgroups occurs after treatment of what ix
>60s may be denovo or decondary similar to ALL DIC or gum infiltration alkylating agents auer rods
what can be done as ALL and AML look the same sometimes
BM aspirate immunophenytyping
myeloproliferative disorders is what
clonal haemopoietic stem cell disorders with an increase production of one or more haemopoitetic cells - in contrast to acute leukaemia maturation is relatively preserved
common features of myeloproliferative disorders
asymp gout weight loss fatigue sweats splenomegaly thrombus in unusual place - no reactive explanation
CML is what
over production of grnaulocutes
pattern of CML
prolif of myeloid cells, chronic phase with intact maturation 3-5y, accelerated phase, blast crisis (acute leukaemia)
when is fatal of CML
fatal without stem cell/BM transplant in chronic phase
ix for CML
normal or low Hb
leucocytes/neurtrophilia
myeldoi precursors
eosinophilia, basophilia, thrombocytosis
philapdelphia
9+22 -> tyrosine kinase which causes abnormal phosphorylation - signalling leading to haematological changes in CML
treatment of CML
imatinib
PRV is overproduction of what
overproduction of RBCs
high Hb/hc accompanied by erythrocytes
ddx of secondary polycythaemia
chronic hypoxia, smoking, erytho secreting tumour
ddx of pseudopolycythaemia
dehydration, diuretics, obesity
aquagenic pruritus
polycythaemia ruba vera
ix for PRV
FBC
film
JAK2 mutation
px with secondary won’t have splenomegaly
JAK2
kinase
activation of erythropoiesis in absence of ligand
treatment of PRV
venesection to haemocrit <0.45
aspirin to reduce thromb risk
hydroxycarbomide - oral chemo
essential thrombocytopenia
high can lead to what
uncontrolled production of abnormal platelets
at high levels can lead to VW dx
symp of ET
MPD symp and bleeding (unpredictable risk of surgery)
microvascular occlusion
ix for ET
exclude reactive thrombosis
JAK2 in 50% CALR in rest MPL mutation
characteristic bone marrow appearance
treatment for ET
aspirin
hydoxycarbamide
anagrelide
interferon alpha last line
myelofibrous idiopathic
marrow failure, marrow fibrosis, extra medullary haemopoesis, leukthrombin film